51 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
”), an agency within the U.S. Department of Health and Human Services (“HHS”). CMS decides whether and to what extent a new product will be covered … in product development or commercialization, or increased costs to assure compliance. The FDA and other agencies, including the Department of Justice
425
EX-99.1
APGN
Apexigen Inc
24 May 23
Business combination disclosure
4:55pm
/ or by contacting Apexigen’s Investor Relations department by email at IR@apexigen.com. Copies of the documents filed with the SEC by Pyxis Oncology will be available … free of charge on Pyxis Oncology’s website at https://ir.pyxisoncology.com/ or by contacting Pyxis Oncology’s Investor Relations department by email
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
pending or, to the Knowledge of the Company, threatened by the Internal Revenue Service (“IRS”), United States Department of Labor or any other … , including the United States Department of Health and Human Services Office for Civil Rights, United States Department of Justice, Federal Trade Commission
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
or, to the Knowledge of the Company, threatened by the Internal Revenue Service (“IRS”), United States Department of Labor or any other Governmental … the United States Department of Health and Human Services Office for Civil Rights, United States Department of Justice, Federal Trade Commission
424B3
xqforjgvn xi
10 Apr 23
Prospectus supplement
4:03pm
424B3
pskl351gr
10 Apr 23
Prospectus supplement
4:02pm
POS AM
xrtgf4pln04l5nr
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
fnco8b1c18mkrsaw
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
frc5uzomjy87
9 Sep 22
Prospectus supplement
4:40pm
424B3
afvsm0191wy7
9 Sep 22
Prospectus supplement
4:38pm
8-K
EX-10.5
a03azejcfpb
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm